SCHEMBL7969689

SCHEMBL7969689

Cc1ccc(C)c(Nc2nc3ccccc3n3cncc23)c1

nearest known ligand 0.75

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LCK P06239 17/20 0.75
POLB P06746 1/20 0.66
LYN P07948 2/20 0.58
BTK Q06187 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982979 0.90 LCK (0.79) LCKPOLBLYNBTK
SCHEMBL7969998 0.88 LCK (0.69) LCKLYNBTK
SCHEMBL7979597 0.88 LCK (0.83) LCKPOLB
SCHEMBL7981469 0.86 LCK (1.00) LCK
SCHEMBL7983627 0.86 LCK (0.76) LCK
SCHEMBL7969485 0.82 LCK (1.00) LCK
SCHEMBL7980299 0.81 LCK (0.75) LCKLYNBTK
SCHEMBL7970071 0.81 LCK (0.72) LCKLYNBTK
SCHEMBL7970810 0.81 LCK (0.69) LCKLYNBTK
SCHEMBL7980767 0.80 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed